US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

93.64

+0.73000.79%

Volume:5K

Turnover:508.98K

Market Cap:406.40M

PE:52.22

High:94.02

Open:94.02

Low:92.76

Close:92.91

52wk High:98.82

52wk Low:67.69

Shares:4.34M

Float Shares:4.34M

Volume Ratio:0.45

T/O Rate:0.13%

Dividend:1.55

Dividend Rate:1.65%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.64

PE(LYR):5.02

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/PBE"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":93.64,"timestamp":1789416000000,"preClose":92.91,"halted":0,"volume":5450,"delay":0,"changeRate":0.00785706597782805,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"Pre-Mkt","change":0.73,"latestTime":"09-15 04:35:59 EDT","open":94.02,"high":94.02,"low":92.7601,"amount":508983.784,"amplitude":0.01356,"askPrice":107.63,"askSize":100,"bidPrice":80.91,"bidSize":100,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":93.64,"sharesOutstanding":3180000,"nav":92.8444,"aum":404801584,"dividendRate":0.0165,"bidAskSpread":0.002045,"postHourTrading":{"tag":"盘后","latestPrice":93.64,"preClose":93.64,"latestTime":"19:30 EDT","volume":11,"amount":1030.34,"timestamp":1789428602593,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4452032406789909,"impliedVol":0.0984,"impliedVolPercentile":0.02},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.4452032406789909,"shares":4340000,"dividePrice":1.5451,"high":94.02,"amplitude":0.01356,"preClose":92.91,"low":92.7601,"week52Low":67.69,"pbRate":"1.64","psRate":"236.74","week52High":98.82,"institutionHeld":0.2552,"latestPrice":93.64,"eps":1.793292,"divideRate":0.0165,"volume":5450,"delay":0,"ttmEps":1.793292,"open":94.02,"prevYearClose":82.15,"prevWeekClose":92.91,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":97.6367,"twentyDayClose":93.7443,"sixtyDayClose":84.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667109456","title":"Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667109456","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667109456?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:33","pubTimestamp":1789461180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.0% to 5.42 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24667.24.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.81, which the company achieved Sept. 16.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.9% and Amgen Inc. remained unchanged.Trading volume totaled 59.4 million shares, compared to the 50-day average of 95.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","BIB","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2242646821.SGD","BBH","IE00BZ08YR35.GBP","LU0058720904.USD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0109394709.USD","LU1023059063.AUD","BK4585","IE0009355771.USD","BK4566","BK4534","IE00B2B36J28.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0889565916.HKD","LU1061106388.HKD","BK1515","LU1983299246.USD","LU2112291526.USD","TBXU","HK0000165453.HKD","LU0868494617.USD","BK4139","LU1057294990.SGD","01177","IE00BZ08YT58.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK1191","BK1521","IE0002141913.USD","BK4533","PBE","PJP","AMGN","BK4581","LU2242652126.USD","LU1571399168.USD","BK4599","BK4588","LU0320765992.SGD","IBBQ","IBB","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695950","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695950?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:35","pubTimestamp":1789418100,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  advanced 1.10% to $381.50 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Amgen Inc. closed 14.66% below its 52-week high of $447.03, which the company achieved on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and AbbVie Inc.  rose 1.81% to $261.77.Trading volume  eclipsed its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU0320765992.SGD","IBBQ","IE0002141913.USD","LU0058720904.USD","BK4566","LU2242646821.SGD","LU2242652126.USD","LU1571399168.USD","LU0889565916.HKD","BBH","BK4599","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","PBE","BK4581","LU1061106388.HKD","LU1983299246.USD","LU2112291526.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","PJP","LU0109394709.USD","LU1023059063.AUD","BK4534","LU1057294990.SGD","BK4585","BK4139","SG9999001440.SGD","IE00B2B36J28.USD","BK4533","IE00BJT1NW94.SGD","AMGN","LU2089984988.USD","04332","TBXU","LU0868494617.USD","IE00B4R5TH58.HKD","BIB","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667070","title":"Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667070","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667070?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:30","pubTimestamp":1789403411,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The phase 3 study A Phase 3 Randomized, Double-blind, Placebo-controlled Stu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LU0320765992.SGD","IBBQ","IE0002141913.USD","LU0058720904.USD","BK4566","LU2242646821.SGD","LU2242652126.USD","LU1571399168.USD","LU0889565916.HKD","BBH","BK4599","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","PBE","BK4581","LU1061106388.HKD","LU1983299246.USD","LU2112291526.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","PJP","LU0109394709.USD","BK4211","BK4534","LU1023059063.AUD","BK4585","BK4139","LU1057294990.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4533","IE00BJT1NW94.SGD","AMGN","LU2089984988.USD","TBXU","LU0868494617.USD","IE00B4R5TH58.HKD","BIB","ISBC","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661729","title":"Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661729","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661729?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:04","pubTimestamp":1789394640,"startTime":"0","endTime":"0","summary":"1404 GMT - Roche Holding and GSK's Chinese partners reported strong clinical-trial data for their respective lung-cancer drug candidates in China-only clinical trials, analysts at J.P. Morgan write in a research note. Both drugs, one from GSK and partner Hansoh Pharmaceutical and another from Roche and MediLink, showed a 54% improvement in overall survival rates in the trials. This seems competitive relative to a 40% benefit shown by Amgen's Imdelltra in a global trial, the analysts say. Roche and MediLink's candidate tam-peli has a better tolerability profile than GSK and Hansoh's ris-rez, they add. Ris-rez has better median overall-survival data, but it will be important to confirm this result in a global trial, according to JPM. GSK shares rise 4.6% and Roche's jump 5.7%, while Hansoh's close 5.1% higher.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","AMGN","LU2112291526.USD","LU0109394709.USD","HRTS","LU1829250122.USD","IE0009355771.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4532","LU1983299246.USD","IE0002141913.USD","BK4533","LU0889565916.HKD","03692","BK4007","BK4534","LU0122379950.USD","BK4566","LU1571399168.USD","LU2242652126.USD","LU0868494617.USD","GSKH","PBE","LU0320765992.SGD","BK4599","BK1589","RHHBY","BBH","LU2468319806.SGD","LU1023059063.AUD","GSK.UK","TBXU","GSK","LU1057294990.SGD","LU1061106388.HKD","CANC","BK4585","IBB","03165","BK4581","PJP","LU2089984988.USD","BK1191","SG9999001440.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IBBQ","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PBE\",params:#limit:6,delay:false,,,undefined,":[]}}